Transcranial magnetic stimulation for the treatment of major depression

QR Code

Transcranial magnetic stimulation for the treatment of major depression

Philip G Janicak, Mehmet E DokucuDepartment of Psychiatry and Behavioral Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USAAbstract: Major depression is often difficult to diagnose accurately. Even when the diagnosis is properly made, standard treatment approaches (eg,...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Janicak PG, Dokucu ME
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2015
Sujets:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/9f92ea46d73040fca33fad49fae71885
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Transcranial magnetic stimulation for treating depression in elderly patients
par: Hizli Sayar G, et autres
Publié: (2013)

Twelve-month, prospective, open-label study of repetitive transcranial magnetic stimulation for major depressive disorder in partial remission
par: Charnsil C, et autres
Publié: (2012)

Effects of repetitive transcranial magnetic stimulation on clinical, social, and cognitive performance in postpartum depression
par: Myczkowski ML, et autres
Publié: (2012)

Navigated transcranial magnetic stimulation in preoperative planning for the treatment of motor area cavernous angiomas
par: Paiva WS, et autres
Publié: (2013)

Cortical mapping with navigated transcranial magnetic stimulation in low-grade glioma surgery
par: Paiva WS, et autres
Publié: (2012)

Desvenlafaxine in the treatment of major depressive disorder
par: Maria Teresa C Lourenco1, et autres
Publié: (2009)

Transcranial magnetic stimulation for the treatment of anxiety disorder
par: Rodrigues PA, et autres
Publié: (2019)

Risk of seizures in transcranial magnetic stimulation: a clinical review to inform consent process focused on bupropion
par: Dobek CE, et autres
Publié: (2015)

Comparative efficacy of escitalopram in the treatment of major depressive disorder
par: Mazen K Ali, et autres
Publié: (2011)

Augmentation treatment in major depressive disorder: focus on aripiprazole
par: J Craig Nelson, et autres
Publié: (2008)

Levomilnacipran for the treatment of major depressive disorder: a review
par: Asnis GA, et autres
Publié: (2015)

Is placebo useful in the treatment of major depression in clinical practice?
par: Marchesi C, et autres
Publié: (2013)

Radioelectric brain stimulation in the treatment of generalized anxiety disorder with comorbid major depression in a psychiatric hospital: a pilot study
par: Fontani V, et autres
Publié: (2011)

Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder
par: Alvarez E, et autres
Publié: (2014)

Rumination: relationships with repetitive transcranial magnetic stimulation treatment of major depressive disorder
par: Stephanie A. Chu, et autres
Publié: (2021)

Efficacy of twice-daily vs once-daily sessions of repetitive transcranial magnetic stimulation in the treatment of major depressive disorder: a retrospective study
par: Modirrousta M, et autres
Publié: (2018)

Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder
par: Aoki A, et autres
Publié: (2014)

Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study
par: Gabriel A
Publié: (2013)

Psychiatric comorbidities in patients with major depressive disorder
par: Thaipisuttikul P, et autres
Publié: (2014)

Selegiline remarkably improved stage 5 treatment-resistant major depressive disorder: a case report
par: Kitaichi Y, et autres
Publié: (2013)

Clinical utility of vilazodone for the treatment of adults with major depressive disorder and theoretical implications for future clinical use
par: Singh M, et autres
Publié: (2012)

The predictive value of somatic and cognitive depressive symptoms for cytokine changes in patients with major depression
par: Dannehl K, et autres
Publié: (2014)

Mitochondrial dysfunction, oxidative stress, and major depressive disorder
par: Tobe EH
Publié: (2013)

The cortisol awakening response and major depression: examining the evidence
par: Dedovic K, et autres
Publié: (2015)

Psychomotor retardation and externally oriented thinking in major depression
par: Luca M, et autres
Publié: (2013)

Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults
par: Robert H Howland
Publié: (2009)

Major depressive disorder: mechanism-based prescribing for personalized medicine
par: Saltiel PF, et autres
Publié: (2015)

Anatomical and functional brain abnormalities in unmedicated major depressive disorder
par: Yang X, et autres
Publié: (2015)

Agomelatine as monotherapy for major depression: an outpatient, open-label study
par: Pecenak J, et autres
Publié: (2013)

A meta-analysis of lipid peroxidation markers in major depression
par: Mazereeuw G, et autres
Publié: (2015)

Evaluation of the efficacy and safety of vilazodone for treating major depressive disorder
par: Zhang XF, et autres
Publié: (2015)

A pilot study differentiating recurrent major depression from bipolar disorder cycling on the depressive pole
par: Marty Hinz, et autres
Publié: (2010)

Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies
par: Han Y, et autres
Publié: (2016)

Neuronavigation-guided high-dose repetitive transcranial magnetic stimulation for the treatment of depressive adolescents with suicidal ideation: a case series
par: Pan F, et autres
Publié: (2018)

Major depressive disorders in chronic hemodialysis patients in Nazareth: identification and assessment
par: Armaly Z, et autres
Publié: (2012)

Getting the balance right: Established and emerging therapies for major depressive disorders
par: Bojana Perovic, et autres
Publié: (2010)

Age-associated decrease in global DNA methylation in patients with major depression
par: Tseng PT, et autres
Publié: (2014)

Agomelatine as monotherapy for major depression: an outpatient, open-label study [Corrigendum]
par: Pecenak J, et autres
Publié: (2013)

Treatments for traumatic brain injury with emphasis on transcranial near-infrared laser phototherapy
par: Morries LD, et autres
Publié: (2015)

Lower serum brain-derived neurotrophic factor levels are associated with failure to achieve remission in patients with major depression after escitalopram treatment
par: Lee BH, et autres
Publié: (2014)